Skip to main content
. 2018 Nov 6;41(5):321–327. doi: 10.1016/j.bj.2018.08.007

Table 4.

Patient cohorts before and after the propensity-score matching.

Before matching
After matching
Variables Death n = 311 Survival n = 2487 OR (95%CI) P Death n = 181 Survival n = 181 OR (95%CI) P
Sex
 Male 205 (65.9) 1659 (66.7) 1.0 (0.75–1.24) 0.780 133 (73.5) 133 (73.5) 1.0 (0.63–1.60) 1.000
 Female 106 (34.1) 828 (33.3) 1.0 (0.81–1.33) 0.780 48 (26.5) 48 (26.5) 1.0 (0.63–1.60) 1.000
Age 56.2 ± 21.4 48.9 ± 21.6 <0.001 52.9 ± 21.5 52.9 ± 21.0 0.980
Co-morbidity
 DM 40 (12.9) 331 (13.3) 1.0 (0.68–1.37) 0.826 13 (7.2) 13 (7.2) 1.0 (0.45–2.22) 1.000
 HTN 86 (27.7) 606 (24.4) 1.2 (0.91–1.55) 0.205 41 (22.7) 41 (22.7) 1.0 (0.61–1.64) 1.000
 CAD 21 (6.8) 73 (2.9) 2.4 (1.45–3.95) <0.001 6 (3.3) 6 (3.3) 1.0 (0.32–3.16) 1.000
 CHF 3 (1.0) 13 (0.5) 1.9 (0.53–6.54) 0.410 0 (0.0) 0 (0.0)
 CVA 15 (4.8) 94 (3.8) 1.3 (0.74–2.25) 0.370 3 (1.7) 3 (1.7) 1.0 (0.20–5.02) 1.000
 ESRD 2 (0.6) 1 (0.0) 16.1 (1.46–177.97) 0.034 0 (0.0) 0 (0.0)
SBP mmHg 141.9 ± 60.1 146.6 ± 38.1 0.184 150.9 ± 49.5 149.2 ± 39.6 0.710
GCS 6.8 ± 4.4 12.5 ± 3.8 <0.001 8.1 ± 4.8 8.0 ± 4.8 0.710
AIS, n (%)
 Head/Neck 275 (88.4) 2026 (81.5) 1.7 (1.21–2.50) 0.002 161 (89.0) 161 (89.0) 1.0 (0.52–1.93) 1.000
 Face 40 (12.9) 635 (25.5) 0.4 (0.31–0.61) <0.001 20 (11.0) 20 (11.0) 1.0 (0.52–1.93) 1.000
 Thorax 77 (24.8) 810 (32.6) 0.7 (0.52–0.89) 0.005 43 (23.8) 43 (23.8) 1.0 (0.62–1.62) 1.000
 Extremity 85 (27.3) 1020 (41.0) 0.5 (0.42–0.70) <0.001 51 (28.2) 51 (28.2) 1.0 (0.63–1.58) 1.000
ISS 25 (25–34) 19 (16–24) <0.001 25 (20–29) 25 (18–29) 0.076
Polytrauma 79 (25.4) 615 (24.7) 1.0 (0.79–1.36) 0.795 45 (24.9) 51 (28.2) 0.5 (0.16–1.32) 0.147